CN104304560A - 一种甜茶红茶菌 - Google Patents
一种甜茶红茶菌 Download PDFInfo
- Publication number
- CN104304560A CN104304560A CN201410620778.2A CN201410620778A CN104304560A CN 104304560 A CN104304560 A CN 104304560A CN 201410620778 A CN201410620778 A CN 201410620778A CN 104304560 A CN104304560 A CN 104304560A
- Authority
- CN
- China
- Prior art keywords
- sweet tea
- tea
- sweet
- kombucha
- beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 111
- 235000013616 tea Nutrition 0.000 title claims abstract description 104
- 241001122767 Theaceae Species 0.000 title abstract 12
- 235000019226 kombucha tea Nutrition 0.000 title abstract 9
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 230000001580 bacterial effect Effects 0.000 claims abstract description 9
- 239000001963 growth medium Substances 0.000 claims abstract description 6
- 244000269722 Thea sinensis Species 0.000 claims description 103
- 235000019225 fermented tea Nutrition 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 22
- 241000894006 Bacteria Species 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 16
- 241000233866 Fungi Species 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 235000006468 Thea sinensis Nutrition 0.000 claims description 8
- 235000020279 black tea Nutrition 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000000855 fermentation Methods 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 3
- 240000003553 Leptospermum scoparium Species 0.000 claims description 3
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 3
- 238000010564 aerobic fermentation Methods 0.000 claims description 3
- 239000003905 agrochemical Substances 0.000 claims description 3
- 238000007796 conventional method Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 16
- 235000013361 beverage Nutrition 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 235000019629 palatability Nutrition 0.000 abstract description 2
- 235000019605 sweet taste sensations Nutrition 0.000 abstract description 2
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000009982 effect on human Effects 0.000 abstract 1
- 235000019614 sour taste Nutrition 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 15
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 230000036541 health Effects 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229960001948 caffeine Drugs 0.000 description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000235342 Saccharomycetes Species 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229910052732 germanium Inorganic materials 0.000 description 3
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 3
- 239000000174 gluconic acid Substances 0.000 description 3
- 235000012208 gluconic acid Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000011669 selenium Substances 0.000 description 3
- 229910052711 selenium Inorganic materials 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229940097043 glucuronic acid Drugs 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010017886 Gastroduodenal ulcer Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 244000078118 Ilex latifolia Species 0.000 description 1
- 235000008706 Ilex latifolia Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- 206010047612 Vitamin B2 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 201000007590 ariboflavinosis Diseases 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000020542 functional tea Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000004223 riboflavin deficiency Diseases 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Tea And Coffee (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
一种甜茶红茶菌。具体包括：以甜茶叶为主要原料制备甜茶，然后再以甜茶为培养基，用红茶菌为菌源，制备出一种新型特色的甜茶红茶菌饮料。通过实施本发明，将甜茶和红茶菌有机结合起来，所组合起来的营养物质更加丰富；甜茶和红茶菌对人体疾病都具有显著的保健功效，二者合二为一后，其功效再相辅相成，而形成的茶饮料其保健功效更为彰显，其综合效果远超单纯甜茶叶及传统的红茶菌饮料。所制备出来的甜茶红菌茶饮料产品形态理想，很好地保留了甜茶原有的营养和功能成分，容易消化吸收，口感酸甜适口，适口性非常好，而且不限制适用人群，是一种兼备饮料及有医药功效的双重功能生态保健饮品。
Description
技术领域
本发明属于一种功能性茶制品的制备技术领域，具体涉及一种甜茶红茶菌。
背景技术
甜茶，学名：Rubus Suatrssimus S.Lee，英文名Sweet tea。为多年生纯天然、原生态、无污染常绿木本植物。野生甜茶多分布在其叶子呈椭圆形，边缘有锯齿，味微甜。内含有的茶多酚、甜茶素、硒、锗等物质。除具备普通绿茶的功效外同时还具有防治心血管疾病、预防中风、防癌作用、预防牙齿疾病等药效，与罗汉果、合浦珍珠、广西香料等齐名为广西四大名品。广西甜茶的甜度很高，每公斤干茶叶的甜度相当于15公斤蔗糖的甜度，每公斤甜茶素相当于300公斤的蔗糖甜度。同时甜茶素是一种二萜葡萄糖低热量甜料，是能替代糖的高甜度而低热能且无毒的天然甜料植物。
野生甜茶具有相当高的营养价值，其中以广西甜茶最为代表，其所含的多种成分，具有清热解毒、防癌抗癌抗过敏、润肺化痰止咳、减肥降脂降压、降低血胆固醇、抑制和廷缓血管硬化、防治冠心病和糖尿病等众多的保健功能。甜茶含丰富的营养物质和人体所必需的微量元素。据广西技术监督局分析测试研究中心等单位测试结果证实：野生甜茶中富含18种氨基酸，每100克干品含氨基酸总量331.54毫克，特别是甜茶中富含人体必须的、人体不能生成，只能从食物中吸收的8种氨基酸。主要有钙0.84％、锌105.5mg/kg、锗5.5μg/kg、硒17.94μg/kg，及钾、镁、磷、铁、钠、铜、铬、锶、锂等多种元素，不含砷铝等有毒物质，不含会产生头晕、心跳加速、心悸、焦虑易怒、心理不适、干扰睡眠、等副作用的咖啡因；其中所含的锗、硒等，均优于一般绿茶和苦丁茶。
除上述所含微量元素外，还富含维生素C、B1、B2、B3、超氧化物岐化酶，鲜甜茶中维生素C的含量高达115mg/100g；特别是还富含最具价值4.1％的生物类黄酮、18.04％的茶多酚和5％的甜茶素。其中，用甜茶素代替蔗糖，可以生产出口味好、热值低且成本低的无糖酸奶，为甜茶素在食品中应用开辟了一条新的途径。
据《广西中药标准》记载，野生甜茶有“清热降火、润肺、祛痰、止咳的功效”。被誉为“神茶”，其药用性和食用性已为地方医药和民间所证实，它还含有3.2％以上的黄酮、8.94％的甜茶茶多酚“1和4-5％的甜茶素。甜茶茶多酚有明显抗氧化、抗突变、防癌、降低胆固醇、降低血液中低密度脂蛋白、抑制血压上升、抑制血糖上升、抑制血小板凝集、抗菌、抗食物过敏、改善肠胃微生物环境、消臭的作用吲，是目前发现最理想的纯天然抗氧化剂，用途十分广泛。
此外，广西甜茶还具有无毒副作用，降血脂、血糖、胆固醇，止咳祛痰，消炎抗过敏，分解黑色素等诸多功能。因此，广西甜茶是一种无毒、高甜度、低热能和具有保健功能的天然甜味植物，是一种理想的糖类替代品，对避免因长期过量的吃糖、致使人体发胖和诱发高血压、糖尿病、心血管病、肾脏等疾病的人们具有良好辅助疗效，是一种极具开发价值的天然植物。
目前，广西野生甜茶除了当做茶叶之外，用其作为原料加工为其他产品还未见有相关报道。
发明内容
本发明的目的就是提供全新的一种甜茶红茶菌。具体包括：以甜茶叶为主要原料制备甜茶，然后再以甜茶为培养基，用红茶菌为菌源，制备出一种新型特色的甜茶红茶菌饮料。
所述的红茶菌是以茶水、糖为原料，经醋酸菌、酵母菌和乳酸菌等多种微生物共同发酵而成的。其中，红茶菌菌液中含有一部分茶叶的浸出物、活的微生物及其代谢产物，这些物质主要包括葡萄糖酸、醋酸、葡萄糖、果糖、蛋白质、氨基酸、维生素、微量元素、茶多酚、咖啡因、乙醇和二氧化碳等。红茶菌还富含维生素C、维生素B等营养素，并含有多种对人体有益的微生物，因此能调节人体生理机能，促进新陈代谢，帮助消化，防止动脉硬化，抗癌，养生强身，成为一种盛行全世界的养生保健饮料。
红茶菌在中国流传应用已有150余年的历史，近些年国内外医学界应用红茶菌的实践表明，红茶菌能治疗多种慢性疾病，如高血压、动脉硬化、冠心病、糖尿病、便秘、痔疮、肥胖症、斑秃、白发、白内障、风湿性关节炎、胃炎、痢疾、贫血、核黄素缺乏等。
根据营养分析，红茶菌饮料主要营养成分及相应的功能如下：
(1)多糖、茶多酚、低聚异麦芽糖、茶碱：提高人体免疫力，增强自身抵抗力；调节血脂，调节血糖；促进双歧杆菌生长，减少肠道腐败物质和致癌物质；增加T-淋巴细胞和B-淋巴细胞的数量，提高机体的防御能力。
(2)醋酸、乳酸、柠檬酸：清理肠胃，帮助消化，防治便秘，提高维生素的稳定性，预防有害病菌、病毒入侵，预防感冒。
(3)咖啡因：提高大脑活力，消除疲劳，振作精神。
(4)红茶菌中含有三种对人体有益的益生菌：酵母菌，醋酸菌和乳酸菌。对人体可起到特殊的保健作用。
(5)清理肠胃，消毒解毒，通畅大便，杀灭有害病菌，增加有益菌落，适用于急慢性胃炎，肠炎，便秘，顽固性便秘消除，顽固性腹泻，痢疾等痊愈。
(6)调理肠胃，食欲不振这增加饮食，饭量大增，营养不良者可恢复健康，特别是可使城乡最常见最难治的胃溃疡，十二指肠胃溃疡，胃下垂等胃病痊愈，反胃，呕吐，反酸水等症状消失。
(7)现代医学证明，醋酸具有消除疲劳、增强食欲、帮助消化、防治高血压和动脉硬化的作用，还具有一定的抗肿瘤、防肥胖，使钙易于被人体吸收、保持骨骼的柔韧以及润肌嫩肤的作用。
(8)肝脏障碍排除，急慢性肝炎、肝硬化痊愈。许多人认为红茶菌的解毒抗癌功能因子之一是葡萄糖醛酸，它是人体肝脏中最主要的解毒物质之一。
(9)红茶菌中存在的葡萄糖二酸1，4内酯可使肝素、透明质酸、硫酸粘多糖以及葡萄糖醛酸的破坏大大减少，帮助身体更有效地排出毒素，防癌抗癌，并缓解关节炎、痛风、气喘和相关组织功能下降所引起的其它不适。
(10)痔疮软化消失，更年期功能障碍减少。红茶菌中的葡萄糖酸能与重金属结合形成水溶性复合物，帮助人体排出有害的重金属元素。有研究表明新的红茶菌饮用者尿中的重金属含量增加。
本发明是通过以下技术方案来实现的：
一种甜茶红茶菌，技术方案中在于：以甜茶叶为主要原料制备甜茶，然后再以甜茶为培养基，用红茶菌为菌源，制备出一种新型特色的甜茶红茶菌饮料。
1、所述的甜茶制备方法如下：
(1)甜茶叶原料采集：采集无农药残留、无变质的新鲜甜茶树的嫩枝及其叶片为原料；
(2)甜茶叶原料处理：将所采集的甜茶其嫩枝及叶片通过晒干至物料水分含量低于8～10％；
(3)粉碎：将晒干的甜茶其枝叶粉碎至能过30～50目得甜茶粉碎物；
(4)原料组成及配比：甜茶粉碎物1份、清水50份；
(5)萃取：将上述甜茶粉碎物和清水同时放入加热容器内并静置浸泡5～6个小时，接着通过加热至水溶液沸腾并保持水溶液沸腾直至容器内的水溶液减少至一半，最后经过过滤得到甜茶原料液。
2、所述的甜茶红茶菌饮料制备方法如下：
(1)原料组成及配比：甜茶原料液100份、红茶菌种2份；
(2)发酵：将上述甜茶原料液和红茶菌种同时放置于干净的广口塑料桶中，然后按常规方法进行好氧发酵；
(3)成品：将甜茶原料液发酵至溶液的PH到达3.5～4.5而得成品甜茶红茶菌饮料。
本发明既有如下优点：
1、本发明所提出的甜茶红茶菌其制备方法不但构思新颖，而且配方简单，加工工艺亦很简单，容易实施。
2、实施本发明所用的主要原料——甜茶，该原料资源丰富，而且容易组织。重要的是甜茶营养丰富，还具有众多的保健功效，是一种绿色天然的养生佳品。
3、制备本发明的菌源——红茶菌，该菌种具有培育方法简单、菌种形成周期短、生产成本低廉、菌种质量稳定等有点；红茶菌中主要含有三种对人体特别有益的益生菌：酵母菌、醋酸菌和乳酸菌，对人体可起到特殊的保健作用；同时，由于红茶菌是用茶叶制备的茶液作为培养基，所以菌液中含有一部分茶叶的浸出物、活的微生物及其代谢产物，这些物质主要包括葡萄糖酸、醋酸、葡萄糖、果糖、蛋白质、氨基酸、维生素、微量元素、茶多酚、咖啡因、乙醇和二氧化碳等。因此，红茶菌不但富含有多种对人体有益的微生物，还含有多种营养物质，能调节人体生理机能、促进新陈代谢、帮助消化、防止动脉硬化、抗癌、养生强身等。
4、通过实施本发明，将甜茶和红茶菌有机结合起来，所组合起来的营养物质更加丰富；甜茶和红茶菌对人体疾病都具有显著的保健功效，二者合二为一后，其功效再相辅相成，而形成的茶饮料其保健功效更为彰显。其综合效果远超单纯甜茶叶及传统的红茶菌饮料。
5、通过实施本发明，所制备出来的甜茶菌茶饮料口感酸甜适口，适口性非常好，是一种兼备饮料及有医药功效的双重功能生态保健饮品。
6、通过实施本发明，制备而成的甜茶菌茶饮料成本非常低，但由于该饮料营养丰富、保健效果好、物美价廉，而且不限制适用人群，特别是因长期过量的吃糖、致使人体发胖和诱发高血压、糖尿病、心血管病、肾脏等疾病的人们，不仅吃了无碍，而且对上述疾病具有良好辅助疗效，所以市场前景非常好。
7、本发明制作出来的产品形态理想，产品很好地保留了甜茶原有的营养和功能成分，容易消化吸收，增强了特殊功能；改变了目前市场上甜茶加工产品稀少的现状，解决了甜茶的产后出路，并带动甜茶相关产业的发展，形成新的经济增长点，具有巨大的经济效益和社会效益。
具体实施方式
下面结合实施例对本发明的方法进一步说明。
一种甜茶红茶菌，技术方案中在于：以甜茶叶为主要原料制备甜茶，然后再以甜茶为培养基，用红茶菌为菌源，制备出一种新型特色的甜茶红茶菌饮料。
具体实施方式如下：
1、制备甜茶原料液：
(1)甜茶叶原料采集：采集无农药残留、无变质的新鲜甜茶树的嫩枝及其叶片为原料；
(2)甜茶叶原料处理：将所采集的甜茶其嫩枝及叶片通过晒干至物料水分含量低于8～10％；
(3)粉碎：将晒干的甜茶其枝叶粉碎至能过30～50目得甜茶粉碎物；
(4)原料组成及配比：甜茶粉碎物1份、清水50份；
(5)萃取：将上述甜茶粉碎物和清水同时放入加热容器内并静置浸泡5～6个小时，接着通过加热至水溶液沸腾并保持水溶液沸腾直至容器内的水溶液减少至一半，最后经过过滤得到甜茶原料液。
2、制备甜茶红茶菌饮料：
(1)原料组成及配比：甜茶原料液100份、红茶菌种2份；
(2)发酵：将上述甜茶原料液和红茶菌种同时放置于干净的广口塑料桶中，然后按常规方法进行好氧发酵；
(3)成品：将甜茶原料液发酵至溶液的PH到达3.5～4.5而得成品甜茶红茶菌饮料。
Claims (1)
1.一种甜茶红茶菌，其特征在于：以甜茶叶为主要原料制备甜茶，然后再以甜茶为培养基，用红茶菌为菌源，制备出一种新型特色的甜茶红茶菌饮料；
所述的甜茶制备方法如下：
(1)甜茶叶原料采集：采集无农药残留、无变质的新鲜甜茶树的嫩枝及其叶片为原料；
(2)甜茶叶原料处理：将所采集的甜茶其嫩枝及叶片通过晒干至物料水分含量低于8～10％；
(3)粉碎：将晒干的甜茶其枝叶粉碎至能过30～50目得甜茶粉碎物；
(4)原料组成及配比：甜茶粉碎物1份、清水50份；
(5)萃取：将上述甜茶粉碎物和清水同时放入加热容器内并静置浸泡5～6个小时，接着通过加热至水溶液沸腾并保持水溶液沸腾直至容器内的水溶液减少至一半，最后经过过滤得到甜茶原料液；
所述的甜茶红茶菌饮料制备方法如下：
(1)原料组成及配比：甜茶原料液100份、红茶菌种2份；
(2)发酵：将上述甜茶原料液和红茶菌种同时放置于干净的广口塑料桶中，然后按常规方法进行好氧发酵；
(3)成品：将甜茶原料液发酵至溶液的PH到达3.5～4.5而得成品甜茶红茶菌饮料。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410620778.2A CN104304560A (zh) | 2014-11-07 | 2014-11-07 | 一种甜茶红茶菌 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410620778.2A CN104304560A (zh) | 2014-11-07 | 2014-11-07 | 一种甜茶红茶菌 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104304560A true CN104304560A (zh) | 2015-01-28 |
Family
ID=52359996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410620778.2A Pending CN104304560A (zh) | 2014-11-07 | 2014-11-07 | 一种甜茶红茶菌 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104304560A (zh) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105995365A (zh) * | 2016-06-29 | 2016-10-12 | 黄秀英 | 以甜茶提取液为载体制备一种虫草生物饮品 |
| CN106036331A (zh) * | 2016-06-28 | 2016-10-26 | 黄秀英 | 一种以辣木提取液为载体制备灵芝生物饮品 |
| CN106036332A (zh) * | 2016-06-29 | 2016-10-26 | 黄秀英 | 以罗汉果提取液为载体制备一种桑黄生物饮品 |
| CN106070852A (zh) * | 2016-06-29 | 2016-11-09 | 黄秀英 | 以甜茶提取液为载体制备一种灵芝生物饮品 |
| CN106071586A (zh) * | 2016-06-29 | 2016-11-09 | 黄秀英 | 以罗汉果提取液为载体制备一种虫草生物饮品 |
| CN106072549A (zh) * | 2016-06-29 | 2016-11-09 | 黄秀英 | 以罗汉果提取液为载体制备一种灵芝生物饮品 |
| CN106107354A (zh) * | 2016-06-28 | 2016-11-16 | 黄秀英 | 一种以辣木提取液为载体制备虫草生物饮品 |
| CN106107355A (zh) * | 2016-06-28 | 2016-11-16 | 黄秀英 | 一种以辣木提取液为载体制备桑黄生物饮品 |
| CN106134765A (zh) * | 2016-06-28 | 2016-11-23 | 黄秀英 | 一种灵芝甜茶虫草菌丝体 |
| CN113303383A (zh) * | 2021-06-09 | 2021-08-27 | 贵州大学 | 一种多穗石柯红茶复合饮料及其制备方法 |
| CN114052105A (zh) * | 2021-11-23 | 2022-02-18 | 中山大学 | 一种红茶菌产品的制备方法及其应用 |
-
2014
- 2014-11-07 CN CN201410620778.2A patent/CN104304560A/zh active Pending
Non-Patent Citations (1)
| Title |
|---|
| 方心芳 等: "茶菌-一种保健饮料", 《生物学通报》 * |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106036331A (zh) * | 2016-06-28 | 2016-10-26 | 黄秀英 | 一种以辣木提取液为载体制备灵芝生物饮品 |
| CN106107354A (zh) * | 2016-06-28 | 2016-11-16 | 黄秀英 | 一种以辣木提取液为载体制备虫草生物饮品 |
| CN106107355A (zh) * | 2016-06-28 | 2016-11-16 | 黄秀英 | 一种以辣木提取液为载体制备桑黄生物饮品 |
| CN106134765A (zh) * | 2016-06-28 | 2016-11-23 | 黄秀英 | 一种灵芝甜茶虫草菌丝体 |
| CN105995365A (zh) * | 2016-06-29 | 2016-10-12 | 黄秀英 | 以甜茶提取液为载体制备一种虫草生物饮品 |
| CN106036332A (zh) * | 2016-06-29 | 2016-10-26 | 黄秀英 | 以罗汉果提取液为载体制备一种桑黄生物饮品 |
| CN106070852A (zh) * | 2016-06-29 | 2016-11-09 | 黄秀英 | 以甜茶提取液为载体制备一种灵芝生物饮品 |
| CN106071586A (zh) * | 2016-06-29 | 2016-11-09 | 黄秀英 | 以罗汉果提取液为载体制备一种虫草生物饮品 |
| CN106072549A (zh) * | 2016-06-29 | 2016-11-09 | 黄秀英 | 以罗汉果提取液为载体制备一种灵芝生物饮品 |
| CN113303383A (zh) * | 2021-06-09 | 2021-08-27 | 贵州大学 | 一种多穗石柯红茶复合饮料及其制备方法 |
| CN114052105A (zh) * | 2021-11-23 | 2022-02-18 | 中山大学 | 一种红茶菌产品的制备方法及其应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104304560A (zh) | 一种甜茶红茶菌 | |
| CN104305427A (zh) | 葡萄红茶菌饮料 | |
| CN104544438A (zh) | 一种功能性植物发酵饮料及其制备方法 | |
| CN104382164A (zh) | 一种灵芝红茶菌 | |
| CN104336719A (zh) | 一种枸杞红茶菌饮料 | |
| CN104304577A (zh) | 一种以金花茶为载体的生物型饮料及其制备方法 | |
| CN104304578A (zh) | 一种火龙果菌茶 | |
| CN104287040A (zh) | 以百香果为原料制备生物型饮料 | |
| CN104273271A (zh) | 一种荷花红茶菌饮料 | |
| CN104351887A (zh) | 一种桑葚茶菌 | |
| CN104273613A (zh) | 一种芒果茶菌饮料 | |
| CN104382129A (zh) | 一种甜玉米红茶菌饮品 | |
| CN104273628A (zh) | 以薏米为原料的生物饮料及其制备方法 | |
| CN104273612A (zh) | 一种甘蔗生物型饮品 | |
| CN105614607A (zh) | 一种润肺止咳的保健饮料及制备方法 | |
| CN104351900A (zh) | 一种以糯米为原料的生物型饮料及其制备方法 | |
| CN104304589A (zh) | 一种铁皮石斛茶菌 | |
| CN104287039A (zh) | 一种以糙米为原料的生物饮料及其制备方法 | |
| CN104286281A (zh) | 一种西瓜红茶菌饮料 | |
| CN104305429A (zh) | 一种发酵型黄秋葵茶饮料 | |
| CN104304561A (zh) | 一种桑黄菌丝红茶菌饮料 | |
| CN103478331A (zh) | 一种火龙果皮茶及其制备方法 | |
| CN104287045A (zh) | 一种大清枣茶菌饮品 | |
| CN104286280A (zh) | 一种木瓜红茶菌饮品 | |
| CN104287044A (zh) | 一种猕猴桃红茶菌饮品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150128 |